Social factors may impact survival in AMLSeptember 14, 2015Leukemia, Myelodysplasia, TransplantationAML
Drug granted orphan designation for AMLSeptember 11, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
T-cell exhaustion may be therapeutic target for AMLSeptember 11, 2015Leukemia, Myelodysplasia, TransplantationAML
Targeting STAT3 to prevent relapse in AMLSeptember 10, 2015Leukemia, Myelodysplasia, TransplantationAML
Persistent mutations tied to relapse, death in AMLAugust 26, 2015Leukemia, Myelodysplasia, TransplantationAML
New HMA shows early promise for MDS/AMLAugust 20, 2015AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Selinexor dose lowered due to sepsis in AML patientsAugust 11, 2015Leukemia, Myelodysplasia, TransplantationAML
Inhibitor could treat range of hematologic disordersJuly 29, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Analysis reveals potential therapeutic target for AMLJuly 24, 2015Leukemia, Myelodysplasia, TransplantationAML
Group creates mouse model of RUNX1-mutated AMLJuly 20, 2015Leukemia, Myelodysplasia, TransplantationAML
Drug may be ‘important treatment option’ for AMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationAML
